Epidemiologic features of human babesiosis in Wisconsin, 1996-2005

Christopher Pfeiffer, James J. Kazmierczak, Jeffrey P. Davis

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To characterize epidemiologic, clinical, and laboratory features of babesiosis occurring in Wisconsin residents. Design: Conduct a review of all cases of babesiosis reported to the Wisconsin Division of Public Health with onsets during 1996-2005. For case patients with onsets during 2004, pertinent medical records were reviewed and patient interviews were performed. Interventions: Increase awareness of the occurrence and recent trends and facilitate prompt, appropriate diagnosis and treatment of babesiosis. Increase awareness among clinicians of the Infectious Diseases Society of America guidelines for the management of babesiosis, Lyme disease, and human granulocytic anaplasmosis. Main Outcome Measures: The study represents an analysis of data received through passive surveillance of a disease that is officially reportable to the Wisconsin Division of Public Health. Other than the description of the occurrence of babesiosis among Wisconsin residents, there were no planned outcome measures. Results: Of the 32 cases of babesiosis reported to the DPH during the study interval, 23 (72%) occurred during 2004 and 2005. The majority of cases occurred in northwestern and west-central Wisconsin. At least 6 patients were co-infected with other tick-borne pathogens. Anemia, thrombocytopenia, and elevation of liver transaminase levels were the most notable laboratory abnormalities among case patients. Conclusions: The apparent increased incidence in babesiosis among Wisconsin residents should impact clinicians' workups for acute febrile illness with known tick exposure, especially in northwest and west central Wisconsin. Babesiosis should now also be considered in patients diagnosed with Lyme disease who have marked constitutional symptoms, especially those with anemia or thrombocytopenia.

Original languageEnglish (US)
Pages (from-to)191-195
Number of pages5
JournalWisconsin Medical Journal
Volume106
Issue number4
StatePublished - Sep 3 2007
Externally publishedYes

Fingerprint

Babesiosis
Lyme Disease
Ticks
Thrombocytopenia
Anemia
Public Health
Anaplasmosis
Outcome Assessment (Health Care)
Transaminases
Medical Records
Fever
Guidelines
Interviews
Liver
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Epidemiologic features of human babesiosis in Wisconsin, 1996-2005. / Pfeiffer, Christopher; Kazmierczak, James J.; Davis, Jeffrey P.

In: Wisconsin Medical Journal, Vol. 106, No. 4, 03.09.2007, p. 191-195.

Research output: Contribution to journalArticle

Pfeiffer, C, Kazmierczak, JJ & Davis, JP 2007, 'Epidemiologic features of human babesiosis in Wisconsin, 1996-2005', Wisconsin Medical Journal, vol. 106, no. 4, pp. 191-195.
Pfeiffer, Christopher ; Kazmierczak, James J. ; Davis, Jeffrey P. / Epidemiologic features of human babesiosis in Wisconsin, 1996-2005. In: Wisconsin Medical Journal. 2007 ; Vol. 106, No. 4. pp. 191-195.
@article{3920fab2b3ab44a3a828cb8b5f735169,
title = "Epidemiologic features of human babesiosis in Wisconsin, 1996-2005",
abstract = "Objective: To characterize epidemiologic, clinical, and laboratory features of babesiosis occurring in Wisconsin residents. Design: Conduct a review of all cases of babesiosis reported to the Wisconsin Division of Public Health with onsets during 1996-2005. For case patients with onsets during 2004, pertinent medical records were reviewed and patient interviews were performed. Interventions: Increase awareness of the occurrence and recent trends and facilitate prompt, appropriate diagnosis and treatment of babesiosis. Increase awareness among clinicians of the Infectious Diseases Society of America guidelines for the management of babesiosis, Lyme disease, and human granulocytic anaplasmosis. Main Outcome Measures: The study represents an analysis of data received through passive surveillance of a disease that is officially reportable to the Wisconsin Division of Public Health. Other than the description of the occurrence of babesiosis among Wisconsin residents, there were no planned outcome measures. Results: Of the 32 cases of babesiosis reported to the DPH during the study interval, 23 (72{\%}) occurred during 2004 and 2005. The majority of cases occurred in northwestern and west-central Wisconsin. At least 6 patients were co-infected with other tick-borne pathogens. Anemia, thrombocytopenia, and elevation of liver transaminase levels were the most notable laboratory abnormalities among case patients. Conclusions: The apparent increased incidence in babesiosis among Wisconsin residents should impact clinicians' workups for acute febrile illness with known tick exposure, especially in northwest and west central Wisconsin. Babesiosis should now also be considered in patients diagnosed with Lyme disease who have marked constitutional symptoms, especially those with anemia or thrombocytopenia.",
author = "Christopher Pfeiffer and Kazmierczak, {James J.} and Davis, {Jeffrey P.}",
year = "2007",
month = "9",
day = "3",
language = "English (US)",
volume = "106",
pages = "191--195",
journal = "Wisconsin Medical Journal",
issn = "0043-6542",
publisher = "State Medical Society of Wisconsin",
number = "4",

}

TY - JOUR

T1 - Epidemiologic features of human babesiosis in Wisconsin, 1996-2005

AU - Pfeiffer, Christopher

AU - Kazmierczak, James J.

AU - Davis, Jeffrey P.

PY - 2007/9/3

Y1 - 2007/9/3

N2 - Objective: To characterize epidemiologic, clinical, and laboratory features of babesiosis occurring in Wisconsin residents. Design: Conduct a review of all cases of babesiosis reported to the Wisconsin Division of Public Health with onsets during 1996-2005. For case patients with onsets during 2004, pertinent medical records were reviewed and patient interviews were performed. Interventions: Increase awareness of the occurrence and recent trends and facilitate prompt, appropriate diagnosis and treatment of babesiosis. Increase awareness among clinicians of the Infectious Diseases Society of America guidelines for the management of babesiosis, Lyme disease, and human granulocytic anaplasmosis. Main Outcome Measures: The study represents an analysis of data received through passive surveillance of a disease that is officially reportable to the Wisconsin Division of Public Health. Other than the description of the occurrence of babesiosis among Wisconsin residents, there were no planned outcome measures. Results: Of the 32 cases of babesiosis reported to the DPH during the study interval, 23 (72%) occurred during 2004 and 2005. The majority of cases occurred in northwestern and west-central Wisconsin. At least 6 patients were co-infected with other tick-borne pathogens. Anemia, thrombocytopenia, and elevation of liver transaminase levels were the most notable laboratory abnormalities among case patients. Conclusions: The apparent increased incidence in babesiosis among Wisconsin residents should impact clinicians' workups for acute febrile illness with known tick exposure, especially in northwest and west central Wisconsin. Babesiosis should now also be considered in patients diagnosed with Lyme disease who have marked constitutional symptoms, especially those with anemia or thrombocytopenia.

AB - Objective: To characterize epidemiologic, clinical, and laboratory features of babesiosis occurring in Wisconsin residents. Design: Conduct a review of all cases of babesiosis reported to the Wisconsin Division of Public Health with onsets during 1996-2005. For case patients with onsets during 2004, pertinent medical records were reviewed and patient interviews were performed. Interventions: Increase awareness of the occurrence and recent trends and facilitate prompt, appropriate diagnosis and treatment of babesiosis. Increase awareness among clinicians of the Infectious Diseases Society of America guidelines for the management of babesiosis, Lyme disease, and human granulocytic anaplasmosis. Main Outcome Measures: The study represents an analysis of data received through passive surveillance of a disease that is officially reportable to the Wisconsin Division of Public Health. Other than the description of the occurrence of babesiosis among Wisconsin residents, there were no planned outcome measures. Results: Of the 32 cases of babesiosis reported to the DPH during the study interval, 23 (72%) occurred during 2004 and 2005. The majority of cases occurred in northwestern and west-central Wisconsin. At least 6 patients were co-infected with other tick-borne pathogens. Anemia, thrombocytopenia, and elevation of liver transaminase levels were the most notable laboratory abnormalities among case patients. Conclusions: The apparent increased incidence in babesiosis among Wisconsin residents should impact clinicians' workups for acute febrile illness with known tick exposure, especially in northwest and west central Wisconsin. Babesiosis should now also be considered in patients diagnosed with Lyme disease who have marked constitutional symptoms, especially those with anemia or thrombocytopenia.

UR - http://www.scopus.com/inward/record.url?scp=34548214187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548214187&partnerID=8YFLogxK

M3 - Article

C2 - 17844708

AN - SCOPUS:34548214187

VL - 106

SP - 191

EP - 195

JO - Wisconsin Medical Journal

JF - Wisconsin Medical Journal

SN - 0043-6542

IS - 4

ER -